All articles by Manish Kumar
Manish Kumar
Clinical ink announces trial license for the SPUR AI-enabled Digital Engagement and Retention Solution
Industry-leading behavioral science tool SPUR is validated to predict adherence and will be offered through the Clinical ink technology platform
Emboa Medical develops new catheter to improve stroke clot retrieval
The company has licensed Purdue University’s patent-pending TRAP design, a catheter technology that safely removes blood clots by mimicking the efficiency of a boa constrictor’s teeth
EDX Medical develops new prostate cancer diagnosis test
The test detects prostate cancer, identifies its stage and aggressiveness, and reveals genetic risks, aiming to accelerate personalised treatment
ReadySet partners with LGI for software integrations for Meditech users
Partnership allows Meditech software users to easily connect with advanced applications, optimizing bill-only processes and improving the efficiency of the surgical supply chain
Philatron launches SLINKY-DESIGNED FlexyCord coiled cords
Philatron’s Slinky-designed FlexyCord coiled cords are built to enhance medical devices, healthcare equipment, and life-saving applications by providing a safer, more reliable connection in critical spaces
BD recalls certain lot of ChloraPrep Applicators over fungal contamination risk
Aspergillus penicillioides in packaging may contaminate applicators or healthcare’s gloves, compromising the sterile field and increasing infection risks
Navi Medical gains FDA clearance for Neonav ECG Tip Location System
The Neonav ECG Tip Location System advances vascular access care for critically ill newborns and children, supporting neonatal and paediatric patients in the US
Stryker launches ProCeed hospital bed
New hospital bed helps caregivers deliver efficient and quality care in markets outside the U.S.
Johnson & Johnson to resume US VARIPULSE cases
Investigation found that VARIPULSE devices operate as intended
Roche Elecsys sFlt-1/PlGF ratio wins FDA nod for preeclampsia risk stratification
The test stratifies pregnant women with hypertensive disorders to predict and improve outcomes for severe preeclampsia within two weeks